This section is all about treatment, assist and care. Sonidegib (Odomzo®), a second oral hedgehog inhibitor drug, was accredited by the FDA in 2015 for sufferers with regionally advanced BCCs, specifically sufferers whose tumors have recurred following surgical procedure or radiation therapy, or who are usually not candidates for surgical … Read the rest